{"id":63245,"date":"2026-04-15T22:09:25","date_gmt":"2026-04-15T14:09:25","guid":{"rendered":"https:\/\/flcube.com\/?p=63245"},"modified":"2026-04-15T22:09:26","modified_gmt":"2026-04-15T14:09:26","slug":"autobio-diagnostics-expands-global-ivd-footprint-with-dual-vietnam-partnerships","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=63245","title":{"rendered":"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships"},"content":{"rendered":"\n<p><strong>Autobio Diagnostics Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/603658:SHA\">SHA: 603658<\/a>) announced this week it has executed <strong>separate strategic partnership agreements<\/strong> with <strong>Vietnam Private Medical Association (VPMA)<\/strong> and <strong>Hop Luc Group<\/strong>, marking a significant step in the company&#8217;s expansion into the <strong>global in vitro diagnostics (IVD) market<\/strong> and establishing a strong foothold in Vietnam&#8217;s rapidly growing private healthcare sector.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-overview\">Partnership Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Partner<\/th><th>Organization Type<\/th><th>Strategic Focus<\/th><\/tr><\/thead><tbody><tr><td><strong>Vietnam Private Medical Association (VPMA)<\/strong><\/td><td>Professional medical association<\/td><td>Industry standardization and clinical integration<\/td><\/tr><tr><td><strong>Hop Luc Group<\/strong><\/td><td>Private healthcare conglomerate<\/td><td>Commercial distribution and operational implementation<\/td><\/tr><tr><td><strong>Combined Reach<\/strong><\/td><td>National coverage across Vietnam&#8217;s private medical sector<\/td><td>Comprehensive market penetration strategy<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-portfolio-alignment\">Technology Portfolio Alignment<\/h2>\n\n\n\n<p><strong>Autobio Diagnostics<\/strong> brings specialized expertise in core IVD technologies that directly address Vietnam&#8217;s clinical diagnostic needs:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Immunoassays<\/strong>: Advanced automated platforms for hormone, tumor marker, and infectious disease testing<\/li>\n\n\n\n<li><strong>Microbiological Testing<\/strong>: Comprehensive solutions for bacterial identification and antimicrobial susceptibility testing<\/li>\n\n\n\n<li><strong>Quality Standards<\/strong>: High-quality products meeting international regulatory requirements<\/li>\n\n\n\n<li><strong>Technical Support<\/strong>: Integrated service and training programs to ensure optimal implementation<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-market-rationale\">Strategic Market Rationale<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-vietnam-healthcare-landscape\">Vietnam Healthcare Landscape<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Private Sector Growth<\/strong>: Rapid expansion of private hospitals and clinics creating demand for advanced diagnostic solutions<\/li>\n\n\n\n<li><strong>Diagnostic Infrastructure<\/strong>: Need for standardized, high-quality IVD systems to support clinical decision-making<\/li>\n\n\n\n<li><strong>Regulatory Environment<\/strong>: Increasing emphasis on quality standards and international accreditation<\/li>\n\n\n\n<li><strong>Market Size<\/strong>: Vietnam represents one of Southeast Asia&#8217;s fastest-growing healthcare markets with 100+ million population<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-autobio-s-competitive-advantages\">Autobio&#8217;s Competitive Advantages<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Technology Match<\/strong>: Core competencies in immunoassays and microbiology align with high-volume testing needs<\/li>\n\n\n\n<li><strong>Cost-Effectiveness<\/strong>: Competitive pricing compared to Western IVD manufacturers<\/li>\n\n\n\n<li><strong>Regional Expertise<\/strong>: Proven success in Asian markets with similar healthcare infrastructure challenges<\/li>\n\n\n\n<li><strong>Comprehensive Solutions<\/strong>: End-to-end diagnostic platforms rather than single-test offerings<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-implementation-strategy\">Implementation Strategy<\/h2>\n\n\n\n<p>The dual-partnership approach creates a comprehensive market entry strategy:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>VPMA Partnership<\/strong>: Focuses on <strong>industry standardization<\/strong>, professional education, and clinical guideline development<\/li>\n\n\n\n<li><strong>Hop Luc Partnership<\/strong>: Provides <strong>commercial distribution channels<\/strong>, installation services, and ongoing technical support<\/li>\n\n\n\n<li><strong>Synergistic Impact<\/strong>: Combined approach ensures both technical excellence and market accessibility<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-expected-outcomes\">Expected Outcomes<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-for-vietnam-s-healthcare-system\">For Vietnam&#8217;s Healthcare System<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Standardization<\/strong>: Consistent quality standards across private medical facilities<\/li>\n\n\n\n<li><strong>Efficiency Enhancement<\/strong>: Streamlined diagnostic workflows and reduced turnaround times<\/li>\n\n\n\n<li><strong>Service Quality<\/strong>: Improved diagnostic accuracy supporting better patient outcomes<\/li>\n\n\n\n<li><strong>Capacity Building<\/strong>: Enhanced technical capabilities through training and knowledge transfer<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-for-autobio-diagnostics\">For Autobio Diagnostics<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Entry<\/strong>: Establishes beachhead in strategically important Southeast Asian market<\/li>\n\n\n\n<li><strong>Revenue Diversification<\/strong>: Reduces dependency on domestic Chinese market<\/li>\n\n\n\n<li><strong>Global Brand Building<\/strong>: Demonstrates international competitiveness in IVD sector<\/li>\n\n\n\n<li><strong>Platform for Expansion<\/strong>: Creates foundation for broader ASEAN market penetration<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-industry-implications\">Industry Implications<\/h2>\n\n\n\n<p>This strategic move reflects the <strong>broader trend of Chinese IVD manufacturers<\/strong> expanding globally by leveraging competitive advantages in technology, pricing, and regional market understanding. Vietnam&#8217;s healthcare modernization efforts create ideal conditions for high-quality, cost-effective diagnostic solutions from established Asian manufacturers.<\/p>\n\n\n\n<p>The partnership model\u2014combining professional association collaboration with commercial distribution partnerships\u2014represents an innovative approach to market entry that addresses both technical and commercial barriers simultaneously.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-forward-outlook\">Forward Outlook<\/h2>\n\n\n\n<p>Autobio&#8217;s Vietnam expansion positions the company to potentially replicate this successful model across other emerging markets in Southeast Asia and beyond. The focus on private healthcare sectors, which often operate with greater flexibility than public systems, provides an efficient pathway for international IVD companies to establish market presence and demonstrate value before pursuing broader public sector opportunities.<\/p>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding international expansion, partnership outcomes, and market opportunities for Autobio Diagnostics in Vietnam and globally. Actual results may differ due to risks including regulatory approvals, competitive dynamics, currency fluctuations, and evolving healthcare policies in emerging markets.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Autobio Diagnostics Co., Ltd. (SHA: 603658) announced this week it has executed separate strategic partnership&#8230;<\/p>\n","protected":false},"author":1,"featured_media":63248,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[216,4692,1021],"class_list":["post-63245","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-autobio-diagnostics","tag-hop-luc","tag-sha-603658"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Autobio Diagnostics Co., Ltd. (SHA: 603658) announced this week it has executed separate strategic partnership agreements with Vietnam Private Medical Association (VPMA) and Hop Luc Group, marking a significant step in the company&#039;s expansion into the global in vitro diagnostics (IVD) market and establishing a strong foothold in Vietnam&#039;s rapidly growing private healthcare sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=63245\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships\" \/>\n<meta property=\"og:description\" content=\"Autobio Diagnostics Co., Ltd. (SHA: 603658) announced this week it has executed separate strategic partnership agreements with Vietnam Private Medical Association (VPMA) and Hop Luc Group, marking a significant step in the company&#039;s expansion into the global in vitro diagnostics (IVD) market and establishing a strong foothold in Vietnam&#039;s rapidly growing private healthcare sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=63245\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-15T14:09:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-15T14:09:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/1506.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships\",\"datePublished\":\"2026-04-15T14:09:25+00:00\",\"dateModified\":\"2026-04-15T14:09:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245\"},\"wordCount\":583,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/1506.webp\",\"keywords\":[\"Autobio Diagnostics\",\"Hop Luc\",\"SHA: 603658\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63245#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=63245\",\"name\":\"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/1506.webp\",\"datePublished\":\"2026-04-15T14:09:25+00:00\",\"dateModified\":\"2026-04-15T14:09:26+00:00\",\"description\":\"Autobio Diagnostics Co., Ltd. (SHA: 603658) announced this week it has executed separate strategic partnership agreements with Vietnam Private Medical Association (VPMA) and Hop Luc Group, marking a significant step in the company's expansion into the global in vitro diagnostics (IVD) market and establishing a strong foothold in Vietnam's rapidly growing private healthcare sector.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63245\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/1506.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/1506.webp\",\"width\":1080,\"height\":608,\"caption\":\"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63245#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships - Insight, China&#039;s Pharmaceutical Industry","description":"Autobio Diagnostics Co., Ltd. (SHA: 603658) announced this week it has executed separate strategic partnership agreements with Vietnam Private Medical Association (VPMA) and Hop Luc Group, marking a significant step in the company's expansion into the global in vitro diagnostics (IVD) market and establishing a strong foothold in Vietnam's rapidly growing private healthcare sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=63245","og_locale":"en_US","og_type":"article","og_title":"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships","og_description":"Autobio Diagnostics Co., Ltd. (SHA: 603658) announced this week it has executed separate strategic partnership agreements with Vietnam Private Medical Association (VPMA) and Hop Luc Group, marking a significant step in the company's expansion into the global in vitro diagnostics (IVD) market and establishing a strong foothold in Vietnam's rapidly growing private healthcare sector.","og_url":"https:\/\/flcube.com\/?p=63245","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-15T14:09:25+00:00","article_modified_time":"2026-04-15T14:09:26+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/1506.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=63245#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=63245"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships","datePublished":"2026-04-15T14:09:25+00:00","dateModified":"2026-04-15T14:09:26+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=63245"},"wordCount":583,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=63245#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/1506.webp","keywords":["Autobio Diagnostics","Hop Luc","SHA: 603658"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=63245#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=63245","url":"https:\/\/flcube.com\/?p=63245","name":"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=63245#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=63245#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/1506.webp","datePublished":"2026-04-15T14:09:25+00:00","dateModified":"2026-04-15T14:09:26+00:00","description":"Autobio Diagnostics Co., Ltd. (SHA: 603658) announced this week it has executed separate strategic partnership agreements with Vietnam Private Medical Association (VPMA) and Hop Luc Group, marking a significant step in the company's expansion into the global in vitro diagnostics (IVD) market and establishing a strong foothold in Vietnam's rapidly growing private healthcare sector.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=63245#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=63245"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=63245#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/1506.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/1506.webp","width":1080,"height":608,"caption":"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=63245#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Autobio Diagnostics Expands Global IVD Footprint with Dual Vietnam Partnerships"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/1506.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63245"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63245\/revisions"}],"predecessor-version":[{"id":63249,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63245\/revisions\/63249"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/63248"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63245"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}